Fluorescence in neurosurgery: Its diagnostic and therapeutic use. Review of the literature

Christian Ewelt(University of Münster), Markus Holling(University Hospital Münster), Johannes Wölfer(University Hospital Münster), Benjamin Brokinkel(University Hospital Münster), Andrei Nemes(University Hospital Münster), Walter Stummer(University of Münster), Volker Senner(University Hospital Münster)

Journal of Photochemistry and Photobiology B Biology

May 13, 2015

10.1016/j.jphotobiol.2015.05.002

Cited by 80

Related Papers

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

|The Lancet Oncology|2006|3.4k

EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME

|Neurosurgery|2008|1k

Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins: a prospective study in 52 consecutive patients

|Journal of neurosurgery|2000|880

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

|The Lancet|2019|581

What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?

|Neurosurgery|2015|368